IL143149A0 - Stable, attenuated rabies virus mutants and live vaccines thereof - Google Patents

Stable, attenuated rabies virus mutants and live vaccines thereof

Info

Publication number: IL143149A0
Authority: IL; Israel
Prior art keywords: stable; rabies virus; live vaccines; virus mutants; attenuated rabies
Prior art date: 1998-11-27

Application number

IL14314999A

Other languages

English (en)

Original Assignee

Akzo Nobel Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-11-27

Filing date

1999-11-19

Publication date

2002-04-21

1999-11-19 Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv

2002-04-21 Publication of IL143149A0 publication Critical patent/IL143149A0/xx

Links

241000711798 Rabies lyssavirus Species 0.000 title 1
230000002238 attenuated effect Effects 0.000 title 1
229960005486 vaccine Drugs 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20111—Lyssavirus, e.g. rabies virus
- C12N2760/20122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20111—Lyssavirus, e.g. rabies virus
- C12N2760/20161—Methods of inactivation or attenuation

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
Virology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Immunology (AREA)
General Engineering & Computer Science (AREA)
Gastroenterology & Hepatology (AREA)
Biomedical Technology (AREA)
Biophysics (AREA)
Microbiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
General Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

IL14314999A 1998-11-27 1999-11-19 Stable, attenuated rabies virus mutants and live vaccines thereof IL143149A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP98204001		1998-11-27
PCT/EP1999/009101 WO2000032755A1 (fr)	1998-11-27	1999-11-19	Mutants stables du virus de la rage attenue, et vaccins vivants correspondants

Publications (1)

Publication Number	Publication Date
IL143149A0 true IL143149A0 (en)	2002-04-21

Family

ID=8234392

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IL14314999A IL143149A0 (en)	1998-11-27	1999-11-19	Stable, attenuated rabies virus mutants and live vaccines thereof
IL143149A IL143149A (en)	1998-11-27	2001-05-14	Stable mutants of rabies virus and live vaccines prepared from them

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IL143149A IL143149A (en)	1998-11-27	2001-05-14	Stable mutants of rabies virus and live vaccines prepared from them

Country Status (16)

Country	Link
US (1)	US6719981B1 (fr)
EP (1)	EP1131414B1 (fr)
AR (1)	AR021406A1 (fr)
AT (1)	ATE356202T1 (fr)
AU (1)	AU1386100A (fr)
BR (1)	BR9915703B1 (fr)
CA (1)	CA2352231C (fr)
CY (1)	CY1106570T1 (fr)
DE (1)	DE69935445T2 (fr)
DK (1)	DK1131414T3 (fr)
ES (1)	ES2283150T3 (fr)
ID (1)	ID28968A (fr)
IL (2)	IL143149A0 (fr)
PT (1)	PT1131414E (fr)
TR (1)	TR200101445T2 (fr)
WO (1)	WO2000032755A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2257505T3 (es) *	2001-04-23	2006-08-01	Akzo Nobel N.V.	Mutantes de virus de la rabia atenuados y vacunas vivas correspondientes.
HUP0500722A2 (hu) *	2001-07-20	2005-11-28	The University of Georgia Research Foundation, Inc@Á	Attenuált veszettség vírus, a veszettség elleni vakcináláshoz és a központi idegrendszer génterápiájához egy nukleoprotein mutációval a foszforilezés helyén
EP1945780B1 (fr)	2005-10-14	2015-09-16	THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES	Systemes de vecteurs rabiques, compositions et procedes correspondants
US7785874B2 (en) *	2007-01-11	2010-08-31	The Salk Institute For Biological Studies	Compositions and methods for monosynaptic transport
TW200907058A (en)	2007-05-30	2009-02-16	Wyeth Corp	Raccoon poxvirus expressing rabies glycoproteins
US10849975B2 (en)	2011-02-03	2020-12-01	Thomas Jefferson University	Multivalent vaccines for rabies virus and filoviruses
CN103865889B (zh) *	2014-04-03	2015-02-25	深圳市卫光生物制品股份有限公司	狂犬病病毒ctn鸡胚细胞适应株
US11041170B2 (en)	2016-04-04	2021-06-22	Thomas Jefferson University	Multivalent vaccines for rabies virus and coronaviruses

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2580176B1 (fr) *	1985-04-12	1988-02-26	Centre Nat Rech Scient	Vaccin antirabique avirulent
FR2633832B1 (fr) *	1988-07-05	1991-05-31	Virbac	Vaccin antirabique avirulent
FR2693655B1 (fr) *	1992-07-20	1994-10-14	Virbac	Vaccin antirabique avirulent.
SE0002498D0 (sv)	2000-07-03	2000-07-03	Stefan Schwartz	Papillomavirus vaccine
AU2002360311A1 (en)	2001-12-10	2003-06-23	Donaldson Company, Inc.	Exhaust treatment control system for an internal combustion engine
DE102004009653A1 (de)	2004-02-27	2005-09-22	Cycos Ag	Kommunikationsserver und Verfahren zum Aufbau und Betrieb einer Konferenz-Kommunikationsverbindung

1999
- 1999-11-19 ES ES99973064T patent/ES2283150T3/es not_active Expired - Lifetime
- 1999-11-19 IL IL14314999A patent/IL143149A0/xx active IP Right Grant
- 1999-11-19 EP EP99973064A patent/EP1131414B1/fr not_active Expired - Lifetime
- 1999-11-19 ID IDW00200101139A patent/ID28968A/id unknown
- 1999-11-19 DK DK99973064T patent/DK1131414T3/da active
- 1999-11-19 TR TR2001/01445T patent/TR200101445T2/xx unknown
- 1999-11-19 BR BRPI9915703-9A patent/BR9915703B1/pt not_active IP Right Cessation
- 1999-11-19 AU AU13861/00A patent/AU1386100A/en not_active Abandoned
- 1999-11-19 US US09/856,653 patent/US6719981B1/en not_active Expired - Lifetime
- 1999-11-19 WO PCT/EP1999/009101 patent/WO2000032755A1/fr not_active Ceased
- 1999-11-19 PT PT99973064T patent/PT1131414E/pt unknown
- 1999-11-19 CA CA2352231A patent/CA2352231C/fr not_active Expired - Fee Related
- 1999-11-19 AT AT99973064T patent/ATE356202T1/de active
- 1999-11-19 DE DE69935445T patent/DE69935445T2/de not_active Expired - Lifetime
- 1999-11-26 AR ARP990106028A patent/AR021406A1/es not_active Application Discontinuation
2001
- 2001-05-14 IL IL143149A patent/IL143149A/en not_active IP Right Cessation
2007
- 2007-05-09 CY CY20071100622T patent/CY1106570T1/el unknown

Also Published As

Publication number	Publication date
CA2352231C (fr)	2010-06-01
ID28968A (id)	2001-07-19
EP1131414A1 (fr)	2001-09-12
BR9915703B1 (pt)	2012-09-04
CA2352231A1 (fr)	2000-06-08
ATE356202T1 (de)	2007-03-15
BR9915703A (pt)	2001-08-14
IL143149A (en)	2007-12-03
DE69935445D1 (de)	2007-04-19
CY1106570T1 (el)	2012-01-25
TR200101445T2 (tr)	2001-10-22
PT1131414E (pt)	2007-04-30
AU1386100A (en)	2000-06-19
ES2283150T3 (es)	2007-10-16
WO2000032755A1 (fr)	2000-06-08
DK1131414T3 (da)	2007-06-18
EP1131414B1 (fr)	2007-03-07
DE69935445T2 (de)	2007-11-29
US6719981B1 (en)	2004-04-13
AR021406A1 (es)	2002-07-17

Legal Events

Date	Code	Title	Description
2008-04-13	FF	Patent granted
2008-06-05	KB	Patent renewed

Publication	Publication Date	Title
GB2337755B (en)	2003-10-29	Virus vaccine
GB9711964D0 (en)	1997-08-06	Live attenuated vaccines
HUP0103908A3 (en)	2003-10-28	Novel infulenza virus vaccine composition
AU3448797A (en)	1998-01-14	Avian recombinant live vaccine using, as vector, the avian infectious laryngotracheitis virus
AU5562798A (en)	1998-07-15	Recombinant live avian vaccine, using as vector the avian infectious laryngotracheitis virus.
AU6217798A (en)	1998-08-25	Avian recombinant live vaccine using, as vector, the avian infectious laryngotracheitis virus
ZA200201834B (en)	2004-04-28	Vaccine against HBV and HPV.
AU1508699A (en)	1999-06-16	Live attenuated influenza vaccine
AU7501898A (en)	1998-12-11	Live attenuated virus vaccines for equine encephalitis viruses
ZA200201816B (en)	2003-05-28	A vaccine composition and method of using the same.
IL153879A0 (en)	2003-07-31	Modified virus
ZA973642B (en)	1997-11-25	DNA vaccine formulations.
GB9826069D0 (en)	1999-01-20	HIV vaccine
IL137449A0 (en)	2001-07-24	Live vaccine against brucellosis
IL143149A0 (en)	2002-04-21	Stable, attenuated rabies virus mutants and live vaccines thereof
GB9822714D0 (en)	1998-12-09	Vaccines
IL139467A0 (en)	2001-11-25	Vaccine
AU2001234616A1 (en)	2001-08-07	Vaccine composition, process and methods
IL139269A0 (en)	2001-11-25	Hepatitis vaccine
GB2344590B (en)	2000-11-08	Attenuated poliovirus vaccine
AU4957800A (en)	2000-12-18	Vaccine against isa virus
AU3487799A (en)	1999-11-01	Improved live attenuated viruses for use as vectors or vaccines
AU2144499A (en)	1999-08-09	Live attenuated salmonella vaccine
GB9702990D0 (en)	1997-04-02	Virus vaccine
GB9925432D0 (en)	1999-12-29	Virus preparation